FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

SCA Pharmaceuticals Norepinephrine Bitartrate 8 mg Recall

Norepinephrine Bitartrate 8 mg (32 mcg/mL) in 0

SCA Pharmaceuticals, LLC · Windsor, CT

Risk level
Class II
Reported by FDA
Jul 11, 2018
Recall ID
D-0899-2018
Check your lot numberHow we source this data

Summary

SCA Pharmaceuticals recalled Norepinephrine Bitartrate 8 mg starting Jun 14, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0899-2018 on Jul 11, 2018. Reason: Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

Product description

Norepinephrine Bitartrate 8 mg (32 mcg/mL) in 0.9% Sodium Chloride 250 mL bag, SCA Pharmaceuticals, LLC, Windsor, CT

Lot numbers, UPCs & expiration codes

Lot # 1218000930, 1218000946, 1218001058, 1218001077, 1218001169, 1218001170, 1218001190, 1218001191, 1218001206, 1218001317, Exp 06/18/2018-07/11/2018

Where it was sold

Product was distributed throughout the United States.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0899-2018
Classification
Class II
Status
Terminated
Recall initiated
Jun 14, 2018
FDA report date
Jul 11, 2018
Quantity
1,882 bags
Recall type
Voluntary: Firm initiated
Recalling firm
SCA Pharmaceuticals, LLC

Original FDA data

Every field from FDA enforcement report D-0899-2018, exactly as published.

Show all FDA fields
City
Windsor
State
CT
Status
Terminated
Country
United States
Event ID
80303
Address
755 Rainbow Rd Ste B
Code information
Lot # 1218000930, 1218000946, 1218001058, 1218001077, 1218001169, 1218001170, 1218001190, 1218001191, 1218001206, 1218001317, Exp 06/18/2018-07/11/2018
Postal code
06095-1024
Report date
Jul 11, 2018
Product type
Drugs
Recall number
D-0899-2018
Classification
Class II
Recalling firm
SCA Pharmaceuticals, LLC
Product quantity
1,882 bags
Termination date
Feb 4, 2019
Reason for recall
Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Norepinephrine Bitartrate 8 mg (32 mcg/mL) in 0.9% Sodium Chloride 250 mL bag, SCA Pharmaceuticals, LLC, Windsor, CT
Distribution pattern
Product was distributed throughout the United States.
Recall initiation date
Jun 14, 2018
Initial firm notification
Letter
Center classification date
Jul 2, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0899-2018, published Jul 11, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls